NovaBridge Biosciences (NBP) Cash & Current Investments (2018 - 2026)
NovaBridge Biosciences (NBP) posted Cash & Current Investments of $190.85 million for Q2 2026, up 15.2% from $165.61 million a year earlier.
NovaBridge Biosciences (NBP) Cash & Current Investments (2018 - 2026) Analysis & Trends
At the end of FY2025, NovaBridge Biosciences' Cash & Current Investments came in at $210.84 million, up 21.6% from FY2024.
- Annual Cash & Current Investments shows a five-year compound annual growth rate of -22.1% (FY2020 to FY2025).
- In prior years, NovaBridge Biosciences' Cash & Current Investments was $173.4 million in FY2024 (-46.4%), $323.29 million in FY2023 (-37.1%), $513.75 million in FY2022 (-22.5%) and $663.05 million in FY2021 (-9.7%).
- Quarterly Cash & Current Investments has run from a low of $165.61 million in Q2 2025 to a high of $668.93 million in Q4 2021 over five years.
- On a year-over-year basis, Cash & Current Investments increased in three of the last five quarters, with an average decline of 1.0%.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q3 2025, with growth of 23.8%; the weakest was Q2 2024, with a decline of 50.7%.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | NovaBridge Biosciences | 130.23 Mn | -665.35 Mn | - | 190.85 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 190.85 Mn |
| Dec 31, 2025 | 210.84 Mn |
| Sep 30, 2025 | 228.27 Mn |
| Jun 30, 2025 | 165.61 Mn |
| Mar 31, 2025 | 168.62 Mn |
| Dec 31, 2024 | 173.40 Mn |
| Sep 30, 2024 | 184.39 Mn |
| Jun 30, 2024 | 207.49 Mn |
| Dec 31, 2023 | 321.47 Mn |
| Jun 30, 2023 | 406.18 Mn |
| Dec 31, 2022 | 495.39 Mn |
| Jun 30, 2022 | 585.40 Mn |
| Dec 31, 2021 | 671.18 Mn |
| Jun 30, 2021 | 737.90 Mn |
| Dec 31, 2020 | 734.46 Mn |
| Sep 30, 2020 | 438.50 Mn |
| Jun 30, 2020 | 220.63 Mn |
| Dec 31, 2019 | 4.60 Mn |
| Dec 31, 2018 | 268.17 Mn |
NovaBridge Biosciences Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NBP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "NBP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=NBP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();